Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (NYSE: XTNT) is a medical technology company that develops and commercializes orthobiologics and spinal implant fixation systems used in spinal fusion and other orthopedic procedures. Its biologics include human bone allografts, synthetic bone graft substitutes, amniotic membrane grafts… From the company’s description.
Over the twelve months to Jun 30, 2026, Xtant Medical Holdings, Inc. reported revenue of $109.53M, down 14.3% from a year earlier, and a net loss of $11.14M. Its operating margin was −9.6%, and operations generated $0.57M in cash. In fiscal 2025, it reported revenue of $133.93M, up 14.2% from fiscal 2024, and net income of $4.97M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Xtant Medical Holdings, Inc. does
In the company’s own words
Xtant Medical Holdings, Inc. (NYSE: XTNT) is a medical technology company that develops and commercializes orthobiologics and spinal implant fixation systems used in spinal fusion and other orthopedic procedures. Its biologics include human bone allografts, synthetic bone graft substitutes, amniotic membrane grafts and collagen products; its fixation portfolio includes implants and instruments for cervical, thoracolumbar, sacroiliac and interbody procedures. Surgeons use the products to treat spinal disorders and for applications including trauma, foot and ankle, sports medicine, joint surgery, wound care and surgical repair. Xtant sells in the United States through independent sales and stocking agents, supported by employees and national accounts, and uses distribution partners in Europe, Canada, Mexico, South America and parts of the Pacific region. As of December 31, 2025, its U.S. network included more than 670 independent sales and stocking agents. In December 2025, the company sold its Coflex and CoFix assets and its international hardware business.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- BELGRADE, MT
- Fiscal year end
- December
- CIK
- 1453593
- SIC
- 3841
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Xtant Medical Holdings, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Xtant Medical Holdings, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Xtant Medical Holdings, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Xtant Medical Holdings, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Xtant Medical Holdings, Inc.'s last four quarterly filings that the numbers alone won't show?”